Sort
23,748 grants matching “melanoma”
Regulation of TCF3 by Wnt signaling
$414,061Sergei Y Sokol · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · GM
Regulation of TCF3 by Wnt signaling
$414,061Sergei Y Sokol · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · GM
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$414,046David J Mooney · Harvard University · R01 · FY2020 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$413,953Song Li · University Of California Los Angeles · R01 · FY2021 · CA
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
$413,750Jack A Elias · Yale University · R01 · FY2011 · HL
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
$413,750Jack A Elias · Yale University · R01 · FY2010 · HL
Cigarette Smoke, RIG-like Helicases and Alveolar Remodeling
$413,750Jack A Elias · Yale University · R01 · FY2009 · HL
The role of platelets in protection against oral candidiasis
$413,666Heather Raquel Conti · University Of Toledo Health Sci Campus · R01 · FY2021 · DE
The role of platelets in protection against oral candidiasis
$413,666Heather Raquel Conti · University Of Toledo Health Sci Campus · R01 · FY2023 · DE
Targeting exosomal PDL1 to improve immunotherapy
$413,618Wei Guo · Wistar Institute · P50 · FY2023 · CA
Hedgehog signaling in head and neck cancer stem cells, and its role in resistance
$413,606Antonio Jimeno · University Of Colorado Denver · R01 · FY2011 · CA
Establishing MAGE-A4/RAD18 as a novel cancer-specific chemotherapeutic target
$413,559Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$413,515Drew M. Pardoll · Johns Hopkins University · R01 · FY2020 · AI
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$413,515Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · AI
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
$413,515Drew M. Pardoll · Johns Hopkins University · R01 · FY2019 · AI
Mechanisms of BAP1 activity in human cancer development
$413,488Michele Carbone · University Of Hawaii At Manoa · R01 · FY2020 · CA
Reversing epithelial-mesenchymal transition in metastatic cancer cells using engineered nanomaterials and a mild photothermal effect
$413,479Congzhou Wang · South Dakota School Of Mines And Techn'Y · R15 · FY2022 · CA
Shared Resource: Therapeutic Manufacturing
$413,458Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2017 · CA
Identification of Common Polymorphisms Affecting Angiogenesis
$413,250Robert J D'amato · Boston Children'S Hospital · R01 · FY2013 · EY
Descriptive Studies and Record Linkage
$413,182Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Solar Exposure and Melanoma Survival
$413,130Marianne Berwick · University Of New Mexico · R01 · FY2009 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$413,121Vanderbilt University · U10 · FY2000 · CA
Activation and Regulation Mechanisms of the RAF Kinase Family
$413,050Zhihong Wang · University Of The Sciences Philadelphia · R15 · FY2018 · GM
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapy
$413,046Xiang-Yang Wang · Virginia Commonwealth University · R01 · FY2020 · CA
Development of anti-angiogenesis therapy targeting integrin
$412,996Zhi-Ren Liu · Georgia State University · R01 · FY2014 · CA